Heat shock protein-based vaccines and immunotherapies
US6673348B2 · kind B2 · utility
10Cited by
10References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2001 |
| Grant date | Jan 6, 2004 |
| Priority date | — |
| Expiry date | Mar 10, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for inducing an immune response in a subject, wherein the subject is administered an effective amount of a heat shock protein complexed to a hybrid antigen comprising an antigenic domain and a heat shock protein-binding domain. These methods and compositions may be used in the treatment of infectious diseases and cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.